HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Nimesulide for treatment of acute inflammation of the upper respiratory tract.

Abstract
In a double-blind, parallel four-day trial with 51 patients, the anti-inflammatory, antiexudative, and antipyretic effects of nimesulide were compared with placebo in patients with acute inflammation of the upper respiratory tract. Patients who received nimesulide showed improvement in the signs and symptoms evaluated: pharyngeal redness, tonsillar redness, tonsillar swelling, hoarseness, sore throat, headache, and arthralgia. A statistically significant difference between nimesulide and placebo was evident for all parameters (P less than 0.01). The global use rating of the two drugs showed that nimesulide was useful in 22 (92%) of 24 patients and that placebo was useful in four (16%) of 25 patients (P less than 0.01). There were no side effects associated with nimesulide; one placebo-treated patient had diarrhea and withdrew from the study, and one nimesulide-treated patient withdrew for nonmedical reasons. No variations in laboratory tests were noted.
AuthorsM E Nouri
JournalClinical therapeutics (Clin Ther) Vol. 6 Issue 2 Pg. 142-50 ( 1984) ISSN: 0149-2918 [Print] United States
PMID6367986 (Publication Type: Clinical Trial, Comparative Study, Journal Article)
Chemical References
  • Anti-Inflammatory Agents
  • Sulfonamides
  • nimesulide
Topics
  • Adolescent
  • Adult
  • Aged
  • Anti-Inflammatory Agents (therapeutic use)
  • Clinical Trials as Topic
  • Double-Blind Method
  • Female
  • Hoarseness (drug therapy)
  • Humans
  • Male
  • Middle Aged
  • Pharyngitis (drug therapy)
  • Random Allocation
  • Sulfonamides (therapeutic use)
  • Tonsillitis (drug therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: